Global Dermatology OTC Medications Market Growth 2020-2025
According to this study, over the next five years the Dermatology OTC Medications market will register a 3.4%% CAGR in terms of revenue, the global market size will reach $ 13400 million by 2025, from $ 11730 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dermatology OTC Medications business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology OTC Medications market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Dermatology OTC Medications, covering the supply chain analysis, impact assessment to the Dermatology OTC Medications market size growth rate in several scenarios, and the measures to be undertaken by Dermatology OTC Medications companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
External Use
Oral
The classification of dermatology OTC medications includes external use, oral and the proportion of external use in 2019 is about 93%.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Store
Other
Dermatology OTC medications is widely used in hospital, drug store and other field. The most proportion of dermatology OTC medications is drug store, and the proportion in 2019 is 58.2%.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
CR SANJIU
GSK
Johnson & Johnson
Novartis
Teva
Aurobindo
Mylan
Galderma
Sun Pharmaceutical
Almirall
Lingrui
Dr. Reddy's
Cipla
Bausch Health
Qilu Pharmaceutical
Lupin
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Dermatology OTC Medications consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Dermatology OTC Medications market by identifying its various subsegments.
Focuses on the key global Dermatology OTC Medications manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dermatology OTC Medications with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dermatology OTC Medications submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermatology OTC Medications Consumption 2015-2025
2.1.2 Dermatology OTC Medications Consumption CAGR by Region
2.2 Dermatology OTC Medications Segment by Type
2.2.1 External Use
2.2.2 Oral
2.3 Dermatology OTC Medications Consumption by Type
2.3.1 Global Dermatology OTC Medications Consumption Market Share by Type (2015-2020)
2.3.2 Global Dermatology OTC Medications Revenue and Market Share by Type (2015-2020)
2.3.3 Global Dermatology OTC Medications Sale Price by Type (2015-2020)
2.4 Dermatology OTC Medications Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 Other
2.5 Dermatology OTC Medications Consumption by Application
2.5.1 Global Dermatology OTC Medications Consumption Market Share by Type (2015-2020)
2.5.2 Global Dermatology OTC Medications Value and Market Share by Type (2015-2020)
2.5.3 Global Dermatology OTC Medications Sale Price by Type (2015-2020)
3 Global Dermatology OTC Medications by Company
3.1 Global Dermatology OTC Medications Sales Market Share by Company
3.1.1 Global Dermatology OTC Medications Sales by Company (2018-2020)
3.1.2 Global Dermatology OTC Medications Sales Market Share by Company (2018-2020)
3.2 Global Dermatology OTC Medications Revenue Market Share by Company
3.2.1 Global Dermatology OTC Medications Revenue by Company (2018-2020)
3.2.2 Global Dermatology OTC Medications Revenue Market Share by Company (2018-2020)
3.3 Global Dermatology OTC Medications Sale Price by Company
3.4 Global Dermatology OTC Medications Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Dermatology OTC Medications Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Dermatology OTC Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dermatology OTC Medications by Regions
4.1 Dermatology OTC Medications by Regions
4.2 Americas Dermatology OTC Medications Consumption Growth
4.3 APAC Dermatology OTC Medications Consumption Growth
4.4 Europe Dermatology OTC Medications Consumption Growth
4.5 Middle East & Africa Dermatology OTC Medications Consumption Growth
5 Americas
5.1 Americas Dermatology OTC Medications Consumption by Countries
5.1.1 Americas Dermatology OTC Medications Consumption by Countries (2015-2020)
5.1.2 Americas Dermatology OTC Medications Value by Countries (2015-2020)
5.2 Americas Dermatology OTC Medications Consumption by Type
5.3 Americas Dermatology OTC Medications Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Dermatology OTC Medications Consumption by Regions
6.1.1 APAC Dermatology OTC Medications Consumption by Regions (2015-2020)
6.1.2 APAC Dermatology OTC Medications Value by Regions (2015-2020)
6.2 APAC Dermatology OTC Medications Consumption by Type
6.3 APAC Dermatology OTC Medications Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Dermatology OTC Medications by Countries
7.1.1 Europe Dermatology OTC Medications Consumption by Countries (2015-2020)
7.1.2 Europe Dermatology OTC Medications Value by Countries (2015-2020)
7.2 Europe Dermatology OTC Medications Consumption by Type
7.3 Europe Dermatology OTC Medications Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Dermatology OTC Medications by Countries
8.1.1 Middle East & Africa Dermatology OTC Medications Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Dermatology OTC Medications Value by Countries (2015-2020)
8.2 Middle East & Africa Dermatology OTC Medications Consumption by Type
8.3 Middle East & Africa Dermatology OTC Medications Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dermatology OTC Medications Distributors
10.3 Dermatology OTC Medications Customer
11 Global Dermatology OTC Medications Market Forecast
11.1 Global Dermatology OTC Medications Consumption Forecast (2021-2025)
11.2 Global Dermatology OTC Medications Forecast by Regions
11.2.1 Global Dermatology OTC Medications Forecast by Regions (2021-2025)
11.2.2 Global Dermatology OTC Medications Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Dermatology OTC Medications Forecast by Type
11.8 Global Dermatology OTC Medications Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Information
12.1.2 Dermatology OTC Medications Product Offered
12.1.3 Bayer Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bayer Latest Developments
12.2 CR SANJIU
12.2.1 Company Information
12.2.2 Dermatology OTC Medications Product Offered
12.2.3 CR SANJIU Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CR SANJIU Latest Developments
12.3 GSK
12.3.1 Company Information
12.3.2 Dermatology OTC Medications Product Offered
12.3.3 GSK Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 GSK Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Dermatology OTC Medications Product Offered
12.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Novartis
12.5.1 Company Information
12.5.2 Dermatology OTC Medications Product Offered
12.5.3 Novartis Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novartis Latest Developments
12.6 Teva
12.6.1 Company Information
12.6.2 Dermatology OTC Medications Product Offered
12.6.3 Teva Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Teva Latest Developments
12.7 Aurobindo
12.7.1 Company Information
12.7.2 Dermatology OTC Medications Product Offered
12.7.3 Aurobindo Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Aurobindo Latest Developments
12.8 Mylan
12.8.1 Company Information
12.8.2 Dermatology OTC Medications Product Offered
12.8.3 Mylan Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Mylan Latest Developments
12.9 Galderma
12.9.1 Company Information
12.9.2 Dermatology OTC Medications Product Offered
12.9.3 Galderma Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Galderma Latest Developments
12.10 Sun Pharmaceutical
12.10.1 Company Information
12.10.2 Dermatology OTC Medications Product Offered
12.10.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sun Pharmaceutical Latest Developments
12.11 Almirall
12.11.1 Company Information
12.11.2 Dermatology OTC Medications Product Offered
12.11.3 Almirall Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Almirall Latest Developments
12.12 Lingrui
12.12.1 Company Information
12.12.2 Dermatology OTC Medications Product Offered
12.12.3 Lingrui Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Lingrui Latest Developments
12.13 Dr. Reddy's
12.13.1 Company Information
12.13.2 Dermatology OTC Medications Product Offered
12.13.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Dr. Reddy's Latest Developments
12.14 Cipla
12.14.1 Company Information
12.14.2 Dermatology OTC Medications Product Offered
12.14.3 Cipla Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Cipla Latest Developments
12.15 Bausch Health
12.15.1 Company Information
12.15.2 Dermatology OTC Medications Product Offered
12.15.3 Bausch Health Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Bausch Health Latest Developments
12.16 Qilu Pharmaceutical
12.16.1 Company Information
12.16.2 Dermatology OTC Medications Product Offered
12.16.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Qilu Pharmaceutical Latest Developments
12.17 Lupin
12.17.1 Company Information
12.17.2 Dermatology OTC Medications Product Offered
12.17.3 Lupin Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Lupin Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Dermatology OTC Medications Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of External Use
Table 5. Major Players of Oral
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Dermatology OTC Medications Consumption Market Share by Type (2015-2020)
Table 8. Global Dermatology OTC Medications Revenue by Type (2015-2020) ($ million)
Table 9. Global Dermatology OTC Medications Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Dermatology OTC Medications Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Dermatology OTC Medications Consumption Market Share by Application (2015-2020)
Table 13. Global Dermatology OTC Medications Value by Application (2015-2020)
Table 14. Global Dermatology OTC Medications Value Market Share by Application (2015-2020)
Table 15. Global Dermatology OTC Medications Sale Price by Application (2015-2020)
Table 16. Global Dermatology OTC Medications Sales by Company (2017-2019) (M Units)
Table 17. Global Dermatology OTC Medications Sales Market Share by Company (2017-2019)
Table 18. Global Dermatology OTC Medications Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Dermatology OTC Medications Revenue Market Share by Company (2017-2019)
Table 20. Global Dermatology OTC Medications Sale Price by Company (2017-2019)
Table 21. Global Dermatology OTC Medications Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Dermatology OTC Medications Products Offered
Table 23. Dermatology OTC Medications Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Dermatology OTC Medications Consumption by Regions 2015-2020 (M Units)
Table 25. Global Dermatology OTC Medications Consumption Market Share by Regions 2015-2020
Table 26. Global Dermatology OTC Medications Value by Regions 2015-2020 ($ Millions)
Table 27. Global Dermatology OTC Medications Value Market Share by Regions 2015-2020
Table 28. Americas Dermatology OTC Medications Consumption by Countries (2015-2020) (M Units)
Table 29. Americas Dermatology OTC Medications Consumption Market Share by Countries (2015-2020)
Table 30. Americas Dermatology OTC Medications Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Dermatology OTC Medications Value Market Share by Countries (2015-2020)
Table 32. Americas Dermatology OTC Medications Consumption by Type (2015-2020) (M Units)
Table 33. Americas Dermatology OTC Medications Consumption Market Share by Type (2015-2020)
Table 34. Americas Dermatology OTC Medications Consumption by Application (2015-2020) (M Units)
Table 35. Americas Dermatology OTC Medications Consumption Market Share by Application (2015-2020)
Table 36. APAC Dermatology OTC Medications Consumption by Countries (2015-2020) (M Units)
Table 37. APAC Dermatology OTC Medications Consumption Market Share by Countries (2015-2020)
Table 38. APAC Dermatology OTC Medications Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Dermatology OTC Medications Value Market Share by Regions (2015-2020)
Table 40. APAC Dermatology OTC Medications Consumption by Type (2015-2020) (M Units)
Table 41. APAC Dermatology OTC Medications Consumption Market Share by Type (2015-2020)
Table 42. APAC Dermatology OTC Medications Consumption by Application (2015-2020) (M Units)
Table 43. APAC Dermatology OTC Medications Consumption Market Share by Application (2015-2020)
Table 44. Europe Dermatology OTC Medications Consumption by Countries (2015-2020) (M Units)
Table 45. Europe Dermatology OTC Medications Consumption Market Share by Countries (2015-2020)
Table 46. Europe Dermatology OTC Medications Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Dermatology OTC Medications Value Market Share by Countries (2015-2020)
Table 48. Europe Dermatology OTC Medications Consumption by Type (2015-2020) (M Units)
Table 49. Europe Dermatology OTC Medications Consumption Market Share by Type (2015-2020)
Table 50. Europe Dermatology OTC Medications Consumption by Application (2015-2020) (M Units)
Table 51. Europe Dermatology OTC Medications Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Dermatology OTC Medications Consumption by Countries (2015-2020) (M Units)
Table 53. Middle East & Africa Dermatology OTC Medications Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Dermatology OTC Medications Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Dermatology OTC Medications Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Dermatology OTC Medications Consumption by Type (2015-2020) (M Units)
Table 57. Middle East & Africa Dermatology OTC Medications Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Dermatology OTC Medications Consumption by Application (2015-2020) (M Units)
Table 59. Middle East & Africa Dermatology OTC Medications Consumption Market Share by Application (2015-2020)
Table 60. Dermatology OTC Medications Distributors List
Table 61. Dermatology OTC Medications Customer List
Table 62. Global Dermatology OTC Medications Consumption Forecast by Countries (2021-2025) (M Units)
Table 63. Global Dermatology OTC Medications Consumption Market Forecast by Regions
Table 64. Global Dermatology OTC Medications Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Dermatology OTC Medications Value Market Share Forecast by Regions
Table 66. Global Dermatology OTC Medications Consumption Forecast by Type (2021-2025) (M Units)
Table 67. Global Dermatology OTC Medications Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Dermatology OTC Medications Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Dermatology OTC Medications Value Market Share Forecast by Type (2021-2025)
Table 70. Global Dermatology OTC Medications Consumption Forecast by Application (2021-2025) (M Units)
Table 71. Global Dermatology OTC Medications Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Dermatology OTC Medications Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Dermatology OTC Medications Value Market Share Forecast by Application (2021-2025)
Table 74. Bayer Product Offered
Table 75. Bayer Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Bayer Main Business
Table 77. Bayer Latest Developments
Table 78. Bayer Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 79. CR SANJIU Product Offered
Table 80. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. CR SANJIU Main Business
Table 82. CR SANJIU Latest Developments
Table 83. CR SANJIU Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Product Offered
Table 85. GSK Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. GSK Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Product Offered
Table 90. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Product Offered
Table 95. Novartis Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Novartis Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 99. Teva Product Offered
Table 100. Teva Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Teva Main Business
Table 102. Teva Latest Developments
Table 103. Teva Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Product Offered
Table 105. Aurobindo Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 106. Aurobindo Main Business
Table 107. Aurobindo Latest Developments
Table 108. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Mylan Product Offered
Table 110. Mylan Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Mylan Main Business
Table 112. Mylan Latest Developments
Table 113. Mylan Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 114. Galderma Product Offered
Table 115. Galderma Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Galderma Main Business
Table 117. Galderma Latest Developments
Table 118. Galderma Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 119. Sun Pharmaceutical Product Offered
Table 120. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Sun Pharmaceutical Main Business
Table 122. Sun Pharmaceutical Latest Developments
Table 123. Sun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 124. Almirall Product Offered
Table 125. Almirall Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. Almirall Main Business
Table 127. Almirall Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Almirall Latest Developments
Table 129. Lingrui Product Offered
Table 130. Lingrui Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Lingrui Main Business
Table 132. Lingrui Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Lingrui Latest Developments
Table 134. Dr. Reddy's Product Offered
Table 135. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Dr. Reddy's Main Business
Table 137. Dr. Reddy's Latest Developments
Table 138. Dr. Reddy's Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Cipla Product Offered
Table 140. Cipla Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. Cipla Main Business
Table 142. Cipla Latest Developments
Table 143. Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Bausch Health Product Offered
Table 145. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 146. Bausch Health Main Business
Table 147. Bausch Health Latest Developments
Table 148. Bausch Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Qilu Pharmaceutical Product Offered
Table 150. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 151. Qilu Pharmaceutical Main Business
Table 152. Qilu Pharmaceutical Latest Developments
Table 153. Qilu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Lupin Product Offered
Table 155. Lupin Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 156. Lupin Main Business
Table 157. Lupin Latest Developments
Table 158. Lupin Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Dermatology OTC Medications
Figure 2. Dermatology OTC Medications Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Dermatology OTC Medications Consumption Growth Rate 2015-2025 (M Units)
Figure 5. Global Dermatology OTC Medications Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of External Use
Figure 7. Product Picture of Oral
Figure 8. Global Dermatology OTC Medications Consumption Market Share by Type (2015-2020)
Figure 9. Global Dermatology OTC Medications Value Market Share by Type (2015-2020)
Figure 10. Dermatology OTC Medications Consumed in Hospital
Figure 11. Global Dermatology OTC Medications Market: Hospital (2015-2020) (M Units)
Figure 12. Global Dermatology OTC Medications Market: Hospital (2015-2020) ($ Millions)
Figure 13. Dermatology OTC Medications Consumed in Drug Store
Figure 14. Global Dermatology OTC Medications Market: Drug Store (2015-2020) (M Units)
Figure 15. Global Dermatology OTC Medications Market: Drug Store (2015-2020) ($ Millions)
Figure 16. Dermatology OTC Medications Consumed in Other
Figure 17. Global Dermatology OTC Medications Market: Other (2015-2020) (M Units)
Figure 18. Global Dermatology OTC Medications Market: Other (2015-2020) ($ Millions)
Figure 19. Global Dermatology OTC Medications Consumption Market Share by Application (2015-2020)
Figure 20. Global Dermatology OTC Medications Value Market Share by Application (2015-2020)
Figure 21. Global Dermatology OTC Medications Sales Market Share by Company in 2017
Figure 22. Global Dermatology OTC Medications Sales Market Share by Company in 2019
Figure 23. Global Dermatology OTC Medications Revenue Market Share by Company in 2017
Figure 24. Global Dermatology OTC Medications Revenue Market Share by Company in 2019
Figure 25. Global Dermatology OTC Medications Sale Price by Company in 2019
Figure 26. Global Dermatology OTC Medications Consumption Market Share by Regions 2015-2020
Figure 27. Global Dermatology OTC Medications Value Market Share by Regions 2015-2020
Figure 28. Americas Dermatology OTC Medications Consumption 2015-2020 (M Units)
Figure 29. Americas Dermatology OTC Medications Value 2015-2020 ($ Millions)
Figure 30. APAC Dermatology OTC Medications Consumption 2015-2020 (M Units)
Figure 31. APAC Dermatology OTC Medications Value 2015-2020 ($ Millions)
Figure 32. Europe Dermatology OTC Medications Consumption 2015-2020 (M Units)
Figure 33. Europe Dermatology OTC Medications Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Dermatology OTC Medications Consumption 2015-2020 (M Units)
Figure 35. Middle East & Africa Dermatology OTC Medications Value 2015-2020 ($ Millions)
Figure 36. Americas Dermatology OTC Medications Consumption Market Share by Countries in 2019
Figure 37. Americas Dermatology OTC Medications Value Market Share by Countries in 2019
Figure 38. Americas Dermatology OTC Medications Consumption Market Share by Type in 2019
Figure 39. Americas Dermatology OTC Medications Consumption Market Share by Application in 2019
Figure 40. United States Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 41. United States Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 43. Canada Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 45. Mexico Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Dermatology OTC Medications Consumption Market Share by Countries in 2019
Figure 47. APAC Dermatology OTC Medications Value Market Share by Regions in 2019
Figure 48. APAC Dermatology OTC Medications Consumption Market Share by Type in 2019
Figure 49. APAC Dermatology OTC Medications Consumption Market Share by Application in 2019
Figure 50. China Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 51. China Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 53. Japan Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 55. Korea Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 57. Southeast Asia Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 58. India Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 59. India Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 61. Australia Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Dermatology OTC Medications Consumption Market Share by Countries in 2019
Figure 63. Europe Dermatology OTC Medications Value Market Share by Countries in 2019
Figure 64. Europe Dermatology OTC Medications Consumption Market Share by Type in 2019
Figure 65. Europe Dermatology OTC Medications Consumption Market Share by Application in 2019
Figure 66. Germany Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 67. Germany Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 68. France Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 69. France Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 70. UK Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 71. UK Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 73. Italy Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 75. Russia Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Dermatology OTC Medications Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Dermatology OTC Medications Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Dermatology OTC Medications Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Dermatology OTC Medications Consumption Market Share by Application in 2019
Figure 80. Egypt Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 81. Egypt Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 83. South Africa Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 85. Israel Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 87. Turkey Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Dermatology OTC Medications Consumption Growth 2015-2020 (M Units)
Figure 89. GCC Countries Dermatology OTC Medications Value Growth 2015-2020 ($ Millions)
Figure 90. Global Dermatology OTC Medications Consumption Growth Rate Forecast (2021-2025) (M Units)
Figure 91. Global Dermatology OTC Medications Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 93. Americas Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 94. APAC Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 95. APAC Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 96. Europe Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 97. Europe Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 99. Middle East & Africa Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 100. United States Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 101. United States Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 102. Canada Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 103. Canada Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 104. Mexico Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 105. Mexico Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 106. Brazil Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 107. Brazil Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 108. China Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 109. China Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 110. Japan Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 111. Japan Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 112. Korea Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 113. Korea Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 115. Southeast Asia Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 116. India Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 117. India Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 118. Australia Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 119. Australia Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 120. Germany Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 121. Germany Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 122. France Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 123. France Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 124. UK Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 125. UK Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 126. Italy Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 127. Italy Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 128. Russia Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 129. Russia Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 130. Spain Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 131. Spain Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 132. Egypt Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 133. Egypt Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 134. South Africa Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 135. South Africa Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 136. Israel Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 137. Israel Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 138. Turkey Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 139. Turkey Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Dermatology OTC Medications Consumption 2021-2025 (M Units)
Figure 141. GCC Countries Dermatology OTC Medications Value 2021-2025 ($ Millions)
Figure 142. Bayer Dermatology OTC Medications Market Share (2018-2020)
Figure 143. CR SANJIU Dermatology OTC Medications Market Share (2018-2020)
Figure 144. GSK Dermatology OTC Medications Market Share (2018-2020)
Figure 145. Johnson & Johnson Dermatology OTC Medications Market Share (2018-2020)
Figure 146. Novartis Dermatology OTC Medications Market Share (2018-2020)
Figure 147. Teva Dermatology OTC Medications Market Share (2018-2020)
Figure 148. Aurobindo Dermatology OTC Medications Market Share (2018-2020)
Figure 149. Mylan Dermatology OTC Medications Market Share (2018-2020)
Figure 150. Galderma Dermatology OTC Medications Market Share (2018-2020)
Figure 151. Sun Pharmaceutical Dermatology OTC Medications Market Share (2018-2020)
Figure 152. Almirall Dermatology OTC Medications Market Share (2018-2020)
Figure 153. Lingrui Dermatology OTC Medications Market Share (2018-2020)
Figure 154. Dr. Reddy's Dermatology OTC Medications Market Share (2018-2020)
Figure 155. Cipla Dermatology OTC Medications Market Share (2018-2020)
Figure 156. Bausch Health Dermatology OTC Medications Market Share (2018-2020)
Figure 157. Qilu Pharmaceutical Dermatology OTC Medications Market Share (2018-2020)
Figure 158. Lupin Dermatology OTC Medications Market Share (2018-2020)
